Joe Muldoon
@joejmuldoon
Synthetic, systems, and computational immunologist. Cell therapy @UCSF
ID: 1173610302799306752
16-09-2019 14:51:24
36 Tweet
195 Followers
63 Following
Congratulations Joe Muldoon (Josh Leonard and Bagheri Lab) on your thesis seminar today! #IBiSGrads #IBiSAlumni
A powerful approach for controlling delivery at the single cell level: this was a fun collaboration with HoracioEspinosa, Jack Kessler, and teams Joe Muldoon Northwestern CSB
Need a stocking stuffer? Our study on elucidating and refining synthetic receptor mechanisms is out in final version today Synthetic Biology! Northwestern CSB Northwestern Engineering doi.org/10.1093/synbio…
Our new study on predictive design of mammalian genetic programs is out in Science Advances! We paired engineered genetic parts that have special capabilities with computational models to design circuits that perform sophisticated, useful functions advances.sciencemag.org/content/7/8/ea…
Nice piece on predictive design of mammalian genetic programs - a great collaboration with Bagheri Lab led by Joe Muldoon. Beautiful art by Justin Muir. Northwestern CSB NIBIB Science Advances advances.sciencemag.org/content/7/8/ea… news.northwestern.edu/stories/2021/0…
1/4 We’re excited to share two major papers out Science Translational Medicine showing the many benefits of synNotch CAR circuits for the treatment of solid tumors. Axel Hyrenius-Wittsten, an incredible postdoc Roybal Lab, led the studies in Ovarian Cancer and Mesothelioma. tinyurl.com/drje876u
Thanks NIBIB for highlighting this cool project led by Joe Muldoon with Bagheri Lab Northwestern CSB nibib.nih.gov/news-events/ne…
Excited to share new work w/ co-lead Camillia Azimi, @MarsonLab Jeff Bluestone Roybal Lab: using a method we call 'CAR Pooling', we tested many CARs in multiplex & found new non-T cell signaling domains which improve CAR-T efficacy. biorxiv.org/cgi/content/sh… 👇🧵 1/10
Today we report in Nature Medicine the HLA-independent TCR (HIT). Using CRISPR knockin, we remodeled the TCR specificity to target cell surface antigen in an HLA-Independent fashion and benefit from the TCR's unique sensitivity. 1/4 nature.com/articles/s4159…
Excited to share our paper Cell tinyurl.com/22s9pztn. Ray Liu and Iowis Zhu led the development of clinically optimized and tunable nextgen synNotch receptors dubbed SNIPRs for cell therapies. Thank you UC San Francisco Gladstone Institutes Parker Institute for Cancer Immunotherapy press: tinyurl.com/2p8usz7z
I’m excited to share our report - out now in Nature Biomedical Engineering - of a new approach to CRISPR delivery that is poised to transform the way engineered T cell therapies are manufactured. Visit tinyurl.com/CRISPR-PERC for “how to” details. It’s threadin’ time! (1/11) nature.com/articles/s4155…
Thrilled to report in Nature Biomedical Engineering our new effort to improve the manufacturing and access of gene edited T cells. Awesome collab with the Ross Wilson and @MarsonLab. We developed a protein-based delivery for CRISPR systems in human primary cells. A 🧵 by Ross 👇🏼